A great interview from Authority Magazine with Celularity's CEO Dr. Robert Hariri about what it takes to change an industry.
Celularity Inc.
Biotechnology
Florham Park, NJ 15,199 followers
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Degenerative Diseases
About us
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature’s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases. To learn more visit celularity.com.
- Website
-
http://celularity.com
External link for Celularity Inc.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Florham Park, NJ
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Biotechnology
Locations
-
Primary
Get directions
170 Park Avenue
Florham Park, NJ 07932, US
-
Get directions
33 Technology Drive
Warren, New Jersey 07059, US
Employees at Celularity Inc.
Updates
-
Celularity CEO Dr. Robert Hariri cited in this interesting article on the quantity and quality of data available to the biotech industry and the role of AI in digesting and deciphering it. Link to the full article here: https://lnkd.in/gKpu9wMK
-
Amplifying our success through strategic partnerships and collaboration. In this clip from Celularity's Investor & Analyst R&D day presentation, our CEO Dr. Robert Hariri elaborates on how our internal talent and facilities allow for collaboration and partnerships with leading companies and academic institutions with interests in regenerative therapies. #biotech #stemcells The full replay can be found here: https://lnkd.in/giarMSzS
-
A World Class Facility for Commercial Scale Manufacturing. In this clip from Celularity's Investor & Analyst R&D day presentation, our CEO Dr. Robert Hariri describes the capabilities and opportunities of our manufacturing infrastructure. #biotech #stemcells The full replay is available here: https://lnkd.in/g3qw5i35
-
A clip from Celularity's recent Investor and Analyst R&D Day presentation. The whole presentation is available here: https://lnkd.in/gCxD-mTh #stemcells #stemcelltherapy #celularity
-
Presented data at the ASCO Annual Meeting further demonstrating the potential of combining our placental-derived cell therapy platform with currently available antibody therapies to address difficult-to-treat cancers. https://lnkd.in/gAFHQs5U
-
-
A great Q&A with our CEO, Dr. Robert Hariri, by Drug Target Review about our research on the harnessing of placental derived natural killer cells to combat age-related diseases.
Harnessing natural killer cells to combat age-related diseases
https://www.drugtargetreview.com
-
A great article from Longevity.Technology featuring our CEO, Dr. Robert Hariri, about our work in cellular senescence and the senolytic capabilities of placenta-derived NK cells. #nkcells #placentalstemcells #cellularsenescence
Natural killer cells: harnessing Nature’s senolytic
https://longevity.technology
-
If you missed our Research & Development Day presentation yesterday, you can watch it in its entirety via the link below. It's a firsthand look at current breakthroughs, opportunities, and strategies delivered by our leadership team. Just click the Archived Streaming button, enter your email, and the replay will be immediately viewable on your desktop. https://lnkd.in/gBbYDEPu
-
-
Our Research & Development Day webcast is starting soon - 12p EST. The live-streamed presentation will spotlight the significant breakthroughs within our pioneering placental technology platform and clinical development pipeline. We will also showcase opportunities within its commercial advanced biomaterials business, setting the stage for current and future growth strategies. Participants are also invited to engage with our leadership team during an interactive Q&A session. You can learn more and connect to the webcast here: https://lnkd.in/gBbYDEPu
Investor Relations
https://celularity.com